The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.

A new research paper was published by Aging (Aging-US) on December 3, 2024, in Volume 17, Issue 1, titled "Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing.

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...